QSAM Biosciences Appoints Adriann Sax to Board of Directors Austin, TX; January 25, 2022 - QSAM Biosciences Inc. , a company developing next-generation therapeutic. | January 28, 2022
QSAM Biosciences Appoints Adriann Sax to Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Austin, TX, Jan. 25, 2022 (GLOBE NEWSWIRE) QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®), for the treatment of cancer and related diseases,
indexmarketsresearchApril 24, 2021 1
Each section of the research study is specially prepared to explore key aspects of the global
Rho Associated Protein Kinase 2 Market. For instance, the market dynamics section digs deep into the drivers,type
(AN-3485, AT-13148, BA-1049, BA-1076, KD-025, Others),Application
(Metabolic Disorder, Chronic Obstructive Pulmonary Disease, Contact Dermatitis, Others) restraints, trends, and opportunities of the global Rho Associated Protein Kinase 2 Market.
The latest
Rho Associated Protein Kinase 2 market research report offers a top to bottom analysis of this business sphere in terms of potential industry size, supply chain, growth dynamics, opportunity analysis, and competitive landscape. Furthermore, it extends through abstracts on various industry segments, inclusive of a rundown of the business scenario across the various regional markets. Global Rho Associated Protein Kinase 2 Market Report 2021, Forecast to 2028, The report focus